Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00039104
What this trial is testing

Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT00852007
What this trial is testing

A Study Evaluating Vaccination of Prostate Cancer Patients With Self Dendritic Cells Expressing MUC1

Who this might be right for
Prostate Cancer
Hamilton Health Sciences Corporation 20
Testing effectiveness (Phase 2)Study completedNCT00003307
What this trial is testing

Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer

Who this might be right for
Prostate CancerRadiation Toxicity
University of Arizona 25
Large-scale testing (Phase 3)Study completedNCT00769548
What this trial is testing

Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,322
Testing effectiveness (Phase 2)Study completedNCT00430235
What this trial is testing

BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
British Columbia Cancer Agency 39
Testing effectiveness (Phase 2)Study completedNCT00321646
What this trial is testing

Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy

Who this might be right for
Prostate CancerAdenocarcinoma of the Prostate
Mary-Ellen Taplin, MD 42
Large-scale testing (Phase 3)Active Not RecruitingNCT00430183
What this trial is testing

Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 788
Testing effectiveness (Phase 2)Study completedNCT00915122
What this trial is testing

Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes Prostate

Who this might be right for
Adenocarcinoma of the Prostate
University Health Network, Toronto 81
Testing effectiveness (Phase 2)Study completedNCT00547339
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center 94
Not applicableLooking for participantsNCT04945642
What this trial is testing

High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIC Prostate Cancer AJCC v8+5 more
Jonsson Comprehensive Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT00170157
What this trial is testing

Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaProstate CarcinomaRecurrent Prostate Carcinoma+2 more
Mayo Clinic 112
Testing effectiveness (Phase 2)Study completedNCT00027781
What this trial is testing

MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 37
Testing effectiveness (Phase 2)Study completedNCT04530552
What this trial is testing

Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland

Who this might be right for
Localized Prostate CarcinomaProstate AdenocarcinomaStage I Prostate Cancer AJCC v8+1 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Looking for participantsNCT05168618
What this trial is testing

Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
University of Utah 33
Testing effectiveness (Phase 2)Study completedNCT00091390
What this trial is testing

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 129
Not applicableStudy completedNCT00032058
What this trial is testing

Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
American College of Radiology Imaging Network
Testing effectiveness (Phase 2)Active Not RecruitingNCT03541850
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

Who this might be right for
PSA Level Greater Than 0.03PSA ProgressionStage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7+2 more
Jonsson Comprehensive Cancer Center 92
Testing effectiveness (Phase 2)Ended earlyNCT00937768
What this trial is testing

Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Who this might be right for
Prostate AdenocarcinomaStage IIA Prostate CancerStage IIB Prostate Cancer+2 more
Mayo Clinic 16
Testing effectiveness (Phase 2)UnknownNCT00005960
What this trial is testing

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
PainProstate Cancer
Amgen
Testing effectiveness (Phase 2)Ended earlyNCT01145508
What this trial is testing

Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 10
Next Page